IN8Bio
Lloyd Mitchell is an accomplished accounting professional with extensive experience in various roles across multiple organizations. Currently serving as Associate Director of Accounting at IN8bio since March 2024, Lloyd previously held positions such as Manager of Accounting and Senior Accountant at Axsome Therapeutics, Inc. from November 2021 to March 2024. Lloyd's career also includes experience as Accountant II at Teva Pharmaceuticals, Broker Compensation Associate at Cantor Fitzgerald, and various roles at Oritani Bank and Investors Bank, culminating in a strong background in financial reconciliation and oversight. Educational qualifications include a Master of Science in Forensic Accounting and a Bachelor of Science in Accounting from Southern New Hampshire University, along with an Associate's Degree in Accounting from Bergen Community College.
This person is not in any teams
This person is not in any offices
IN8Bio
1 followers
IN8bio, Inc. (“IN8bio”) is a clinical-stage biotechnology company focused on developing novel therapies for the treatment of cancers by employing allogeneic, autologous and genetically modified gamma-delta T cells.